Article
Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection.
Acta microbiologica et immunologica Hungarica - 1 Dec 2018
Girija Smiline As, Jayaseelan Vijayashree Priyadharsini, Arumugam Paramasivam
Abstract excerpt
Carbapenems are administered as the final drug of choice for treating complicated nosocomial infections caused by multidrug-resistant Acinetobacter baumannii strains. It is currently a worldwide issue that metallo-β-lactamases (MBLs) as carbapenem-hydrolyzing enzymes are one of the major drug resistance mechanisms. This investigation is thus aimed to assess the prevalence and characterize the MBL-producing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
